Axsome

Road closed and detour signs
Biotech

FDA refuses Axsome filing for former Pfizer fibromyalgia asset

Axsome is plotting another phase 3 trial to make up for a study that the FDA deemed inadequate and not well-controlled.
Darren Incorvaia Jun 9, 2025 12:27pm
Graphic of two hands trying to untangle a thread inside someones head

Psychiatry biotech hopes to Transcend PTSD rivals with new data

Dec 5, 2023 5:45pm
rocket

Neumora installs new CEO ahead of pivotal depression trials

Jul 18, 2023 6:30am
drawing graphic of a women-presenting person starting off in the distance

Arrivo's depression med flunks ph. 2, shows benefit for women

Oct 17, 2022 12:38pm
pills

Axsome posts positive phase 3 data for depression drug

May 31, 2022 10:41am
Drug inspection FDA regulatory submission

FDA rejects Axsome’s migraine med, but issues are 'addressable'

May 2, 2022 4:21pm